Logo-bi
Bioimpacts. 2024;14(6): 30087. doi: 10.34172/bi.2024.30087
PMID: 39493894        PMCID: PMC11530967

Review

CRISPR-Cas9 in basic and translational aspects of cancer therapy

Maryam Samareh Salavatipour 1 ORCID, Zahra Poursalehi 2, Negin Hosseini Rouzbahani 3, Sohaib Mohammadyar 4, Mohammad Vasei 5 * ORCID

Cited by CrossRef: 0




As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge